Area of Technology:Life Sciences
Title of the Innovation: FnCas9 Editor Linked Uniform Detection Assay (FELUDA)
Brief About Innovation
Brief: Feluda is a rapid diagnostic kit for COVID-19. The main advantages of Feluda are its affordability, relative ease of use and non-dependency on expensive Q-PCR machines. Innovative ‘Feluda’ test uses cutting-edge Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology for detection of genomic sequence of novel coronavirus. It uses a test protocol that is simple to administer and easy to interpret enabling results to be made available to the medical fraternity in relatively lesser time, as compared to other test protocols.
Beta Version
Copyright © 2023. NRDC - All Rights Reserved
Designed and Developed by Maxtra Technologies.
